Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-28 @ 10:27 PM
Study NCT ID:
NCT06149260
Status:
RECRUITING
Last Update Posted:
2024-03-05
First Post:
2023-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Subcutaneous Semaglutide in Systemic Scleroderma
Sponsor:
Second Xiangya Hospital of Central South University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-16
First Submit QC Date:
None
Study First Post Date:
2023-11-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-02
Last Update Post Date:
2024-03-05
Last Update Post Date Type:
ACTUAL